Evaluation of the Therapeutic Potential of Synthetic Growth Hormone-Releasing Hormone Antagonist MIA-690 as a Cognitive Modulator in a Mouse Model of Gulf War Illness
Authors:
- Luis Manuel Salgueiro-TostaLSLuis Manuel Salgueiro-Tosta
- Arumugam Radhakrishnan JayakumarAJArumugam Radhakrishnan Jayakumar
- William KochenWKWilliam Kochen
- Renzhi CaiRCRenzhi Cai
- Wei ShaWSWei Sha
- Erik JohnsonEJErik Johnson
- James O’callaghanJOJames O’callaghan
- Miklós JászberényiMJMiklós Jászberényi
- Andrew Victor SchallyASAndrew Victor Schally
- Nancy KlimasNKNancy Klimas
Open Access
- 2 September 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (17) , 8516
Abstract
Gulf War illness (GWI) is a multi-symptom disorder affecting veterans of the Persian Gulf operations. Persistent neuroendocrine dysregulation contributes to impairing cognitive capacity and generates anxiety-like behavior. Effective treatments for this illness are challenging due to compromised metabolism, increased oxidative stress and neuroinflammation, perpetuated by chronic stress and hypothalamic–pituitary–adrenal (HPA) axis dysfunction. This neuroinflammation can be alleviated with synthetic antagonistic analogs of the growth hormone-releasing hormone (GHRH) through modulation of the HPA axis. We evaluated the efficacy of the GHRH antagonist analog, MIA-690, against cognitive impairment and anxiety-like behavior in GWI. Mice exposed to an experimental GWI model involving corticosterone (CORT) and diisopropylfluorophosphate (DFP), followed by CORT and lipopolysaccharide (LPS), received a daily subcutaneous dose of 10 μg of MIA-690 for 10 days. Assessments of spatial memory, recognition capacity, somatic health, anxiety and innate survival were carried out, combining the Morris water maze (MWM), novel object recognition (NORT), grip strength (GST), and open field (OFT) tests. Learning efficiency was selectively enhanced in females using the MWM. There were no significant differences in the recall capacity and performance on the OFT, NOR, and GST tasks. Our findings suggest that the MIA-690 dosage is sufficient to improve learning deficits in experimental GWI exposures.Keywords
Funding Information
- U.S. Department of War (W81XWH-17-2-0063)
- the resources of the Institute for Neuro-Immune Medicine at Nova Southeastern University (W81XWH-17-2-0063)
- the Research Services at the Veterans Affairs Department (W81XWH-17-2-0063)
- the Miami VA Healthcare System (W81XWH-17-2-0063)
- the South Florida Veterans Affairs Foundation for Research and Education Inc. (W81XWH-17-2-0063)
This publication has 124 references indexed in Scilit:
- Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyondReviews in Endocrine and Metabolic Disorders, 2024
- Effects of GHRH and its analogues on the Vascular SystemReviews in Endocrine and Metabolic Disorders, 2024
- GHRH and its analogues in central nervous system diseasesReviews in Endocrine and Metabolic Disorders, 2024
- Effects of Caloric Restriction and Intermittent Fasting and Their Combined Exercise on Cognitive Functioning: A ReviewCurrent Nutrition Reports, 2024
- A cellular approach to understanding and treating Gulf War IllnessCellular and Molecular Life Sciences, 2021
- Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to BleomycinLung, 2019
- Effects of Growth Hormone–Releasing Hormone on Cognitive Function in Adults With Mild Cognitive Impairment and Healthy Older AdultsArchives of Neurology, 2012
- Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild‐type p53 and decrease in p21 and mutant p53 proteinsThe Prostate, 2011
- A pilot study of immune network remodeling under challenge in Gulf War IllnessBrain, Behavior, and Immunity, 2011
- Developments of a water-maze procedure for studying spatial learning in the ratJournal of Neuroscience Methods, 1984